Category:

Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

Spending on health care advertising in the U.S. has almost doubled over the past two decades as companies compete for their share of the world’s biggest health care market...Annual health care marketing surged from $17.7 billion in 1997 to at least $29.9 billion in 2016, driven by a rapid spike in spending on direct-to-consumer (DTC) advertisements for prescription drugs, the study found...DTC spending climbed from $2.1 billion to $9.6 billion...Pharmaceutical marketing to health professionals accounted for the biggest outlay, and climbed from $15.6 billion to $20.3 billion despite new policies at hospitals and medical schools designed to limit industry influence over prescribing...

It has been a tumultuous year for science and medicine...We asked a whole host of experts — scientists, CEOs, policymakers, and professors — to weigh in on what themes they expect to see emerge in the next 12 months.

- We’re getting closer to a universal flu vaccine
- The CRISPR story is just getting started …
- And so is the focus on China.
- The opioid crisis isn’t slowing down, either.
- Speaking of cannabis (and psychedelics) … it’s only heating up.
- Cancer research will increasingly focus on organoids.
- You’ll get more control of your health data.
- Broadly, though, expect a reckoning in the AI space.
- None of this will keep prices down.
- We’ll get a clearer picture on antibiotic resistance threats.
- Pharmacies may have to change to stay relevant.

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

The Louisiana Department of Health is seeking a drug manufacturing partner for unrestricted access to curative hepatitis C treatments for Medicaid and incarcerated patients. Rather than pay the partner by prescription, the state would agree to pay a subscription fee similar to the Netflix model of paying a fixed monthly cost rather than paying per movie... The state said the plan is an attempt to help end the hep C epidemic in Louisiana. At least 39,000 people in the state's Medicaid program or in its prisons have the disease... fewer than 3% of Medicaid patients in Louisiana with hep C were treated last year. State officials blamed the lack of treatment on high drug prices.

Nerve stimulation to treat neurological conditions such as Parkinson’s disease, addiction and chronic pain has been around for the past five decades...But the lack of knowledge of its existence — and proven effectiveness — led in part to the rise in the national opioid epidemic, five doctors and engineers said during a panel at CES...This discussion, titled “The Solution to the Opioid Crisis No One is Talking About,”...neuromodulation to treat chronic pain...is a very safe and effective therapy, with a lot of data and publications to back it up...This is a very safe and effective therapy, with a lot of data and publications to back it up.”...electrodes on a needle stimulate nerves in the spine to eliminate pain...Some implants last up to a decade...It’s what Rafael Carbunaru, head of research and development at Boston Scientific, called the “ultimate wearable.”...It sounds like a dream. So why isn’t it the norm in treatment, and why don’t more patients know to ask their doctors about it?...

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.